Studies related to Total Cholesterol and Yerba mate

Consumption Of Yerba Mate ( Ilex Paraguariensis ) Improves Serum Lipid Parameters In Healthy Dyslipidemic Subjects And Provides An Additional LDL-cholesterol Reduction In Individuals On Statin Therapy

Effect Decrease
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 102
Sex Both Genders
Age Range 45-64, 65+
Body Types Obese, Overweight
Notes for this study:
3 servings of yerba tea (330mL) per day for 40 days, in a population of people on statin therapy already.

Yerba Mate was able to lower LDL cholesterol by 8.7% in normolipidemic persons, 8.1-8.6% in dyslipidemics (at 20 and 40 days, respectively).

Non-HDL lipoproteins decreased, and HDL increased by 4.4%. Apolipoprotein B was also found to be significantly reduced by 6%.

All measured effects were slightly more potent in hypercholesterolemic persons.